ZNF701

gene
On this page

Also known as FLJ10891

Summary

ZNF701 (zinc finger protein 701, HGNC:25597) is a protein-coding gene on chromosome 19q13.41, encoding Zinc finger protein 701 (Q9NV72). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 55762 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 121 total — 1 pathogenic
  • MANE Select transcript: NM_018260

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25597
Approved symbolZNF701
Namezinc finger protein 701
Location19q13.41
Locus typegene with protein product
StatusApproved
AliasesFLJ10891
Ensembl geneENSG00000167562
Ensembl biotypeprotein_coding
Entrez55762

Gene structure

Transcript identifiers

Ensembl transcripts: 19 — 12 protein_coding, 5 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay

ENST00000301093, ENST00000391785, ENST00000478039, ENST00000593941, ENST00000596514, ENST00000597158, ENST00000753349, ENST00000753350, ENST00000753351, ENST00000850979, ENST00000850980, ENST00000906409, ENST00000906410, ENST00000906411, ENST00000937256, ENST00000937257, ENST00000937258, ENST00000937259, ENST00000971181

RefSeq mRNA: 7 — MANE Select: NM_018260 NM_001172655, NM_001433681, NM_001433682, NM_001433683, NM_001433684, NM_001433685, NM_018260

CCDS: CCDS33092, CCDS54311

Canonical transcript exons

ENST00000391785 — 4 exons

ExonStartEnd
ENSE000022340095258220252587174
ENSE000025199155257589552576021
ENSE000031716825257028752570330
ENSE000042831295257407752574162

Expression profiles

Bgee: expression breadth ubiquitous, 204 present calls, max score 88.79.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.3754 / max 72.2144, expressed in 1505 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1773125.37541505

Top tissues by expression

274 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
buccal mucosa cellCL:000233688.79gold quality
tendon of biceps brachiiUBERON:000818887.45gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099185.49gold quality
amniotic fluidUBERON:000017385.39gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.82gold quality
tendonUBERON:000004383.95gold quality
calcaneal tendonUBERON:000370183.02gold quality
granulocyteCL:000009480.45gold quality
leukocyteCL:000073879.43gold quality
monocyteCL:000057679.36gold quality
mononuclear cellCL:000084279.09gold quality
colonic epitheliumUBERON:000039779.02gold quality
right uterine tubeUBERON:000130278.96gold quality
sural nerveUBERON:001548877.90gold quality
adrenal tissueUBERON:001830377.79gold quality
rectumUBERON:000105277.68gold quality
right lobe of thyroid glandUBERON:000111977.47gold quality
left lobe of thyroid glandUBERON:000112076.80gold quality
apex of heartUBERON:000209876.67gold quality
endothelial cellCL:000011576.65silver quality
islet of LangerhansUBERON:000000676.60gold quality
stromal cell of endometriumCL:000225576.50gold quality
thyroid glandUBERON:000204676.50gold quality
bloodUBERON:000017876.38gold quality
lower esophagus mucosaUBERON:003583476.13gold quality
mucosa of stomachUBERON:000119976.06gold quality
pancreatic ductal cellCL:000207975.78silver quality
ganglionic eminenceUBERON:000402375.78gold quality
right adrenal gland cortexUBERON:003582775.78gold quality
hindlimb stylopod muscleUBERON:000425275.75gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no3.95

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA1987.1ZNF701More than 3 adjacent zinc fingers
MA1987.2ZNF701More than 3 adjacent zinc fingers

JASPAR matrix evidence (PMIDs): PMID:22955616

miRNA regulators (miRDB)

108 targeting ZNF701, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-3925-3P100.0069.951237
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-3064-3P100.0070.091254
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-480399.9871.993117
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-314899.9775.066478
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-23A-3P99.9574.243163
HSA-MIR-23B-3P99.9574.243163
HSA-MIR-23C99.9573.923192
HSA-MIR-6845-3P99.9466.881439
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-548D-3P99.8770.674362
HSA-MIR-612499.8769.783551
HSA-MIR-548BB-3P99.8670.584354

Literature-anchored findings (GeneRIF, showing 1)

  • Mediating effect of genome-wide DNA methylation on suicidal ideation induced by perceived stress. (PMID:34050117)

Cross-species orthologs

0 orthologs

Paralogs (11): ZNF761 (ENSG00000160336), ZNF816 (ENSG00000180257), ZNF766 (ENSG00000196214), ZNF765 (ENSG00000196417), ZNF860 (ENSG00000197385), ZNF813 (ENSG00000198346), ZNF525 (ENSG00000203326), ZNF468 (ENSG00000204604), ZNF888 (ENSG00000213793), ZNF578 (ENSG00000258405), (ENSG00000269825)

Protein

Protein identifiers

Zinc finger protein 701Q9NV72 (reviewed: Q9NV72)

All UniProt accessions (3): Q9NV72, M0R085, M0R327

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9NV72-11yes
Q9NV72-22

RefSeq proteins (7): NP_001166126, NP_001420610, NP_001420611, NP_001420612, NP_001420613, NP_001420614, NP_060730* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (22 total): zinc finger region 9, sequence variant 7, chain 1, domain 1, region of interest 1, compositionally biased region 1, cross-link 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NV72-F157.650.12

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 271

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 66 (showing top): BLALOCK_ALZHEIMERS_DISEASE_UP, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, CBX5_TARGET_GENES, CBX7_TARGET_GENES, E2F2_TARGET_GENES, ELF2_TARGET_GENES, H1_6_TARGET_GENES, KAT5_TARGET_GENES, ZNF274_TARGET_GENES, ZNF350_TARGET_GENES

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

490 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF701Q6GMV1Q6GMV1447
ZNF701TRIM61Q5EBN2440
ZNF701CYB561D1Q8N8Q1411
ZNF701TAS2R30P59541404
ZNF701OR8U1Q8NH10400
ZNF701HRCT1Q6UXD1399
ZNF701DQX1Q8TE96398
ZNF701DNHD1Q96M86371
ZNF701DCAF4L2Q8NA75370
ZNF701TOP6BLQ8N6T0369
ZNF701SNX11Q9Y5W9365
ZNF701ZER1Q7Z7L7348
ZNF701SLFN14P0C7P3348
ZNF701ZYG11BQ9C0D3326
ZNF701UTP3Q9NQZ2323

IntAct

8 interactions, top by confidence:

ABTypeScore
TRIM28ZNF320psi-mi:“MI:0914”(association)0.530
TRIM28ZNF320psi-mi:“MI:0914”(association)0.350
GPATCH4NOP56psi-mi:“MI:0914”(association)0.350
Mpsi-mi:“MI:0914”(association)0.350
NVLpsi-mi:“MI:0914”(association)0.350
RBM4BZNF320psi-mi:“MI:0914”(association)0.350

BioGRID (18): ZNF701 (Affinity Capture-MS), ZNF701 (Affinity Capture-MS), ZNF701 (Affinity Capture-MS), ZNF701 (Affinity Capture-MS), ZNF701 (Affinity Capture-MS), ZNF701 (Affinity Capture-MS), ZYG11B (Protein-peptide), ZNF701 (Protein-peptide), ZNF701 (Protein-peptide), ZNF701 (Co-crystal Structure), ZNF701 (Affinity Capture-MS), ZER1 (Affinity Capture-Western), ZNF701 (Protein-peptide), ZNF701 (Protein-peptide), ZNF701 (Co-crystal Structure)

ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58

Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

121 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance105
Likely benign7
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
59127GRCh38/hg38 19q13.41-13.43(chr19:51141518-58539965)x3Pathogenic

SpliceAI

545 predictions. Top by Δscore:

VariantEffectΔscore
19:52570327:GGCG:Gdonor_gain1.0000
19:52570328:GCGG:Gdonor_gain1.0000
19:52570329:CGG:Cdonor_loss1.0000
19:52570331:G:GGdonor_gain1.0000
19:52575891:TCA:Tacceptor_loss1.0000
19:52575892:CA:Cacceptor_loss1.0000
19:52575893:A:AGacceptor_gain1.0000
19:52575893:A:ATacceptor_loss1.0000
19:52575893:AG:Aacceptor_gain1.0000
19:52575894:G:GGacceptor_gain1.0000
19:52575894:GG:Gacceptor_gain1.0000
19:52575894:GGGT:Gacceptor_gain1.0000
19:52575894:GGGTC:Gacceptor_gain1.0000
19:52582191:A:AGacceptor_gain1.0000
19:52582193:A:AGacceptor_gain1.0000
19:52582194:T:Gacceptor_gain1.0000
19:52582197:TGTAG:Tacceptor_loss1.0000
19:52582200:A:AGacceptor_gain1.0000
19:52582200:AGAT:Aacceptor_loss1.0000
19:52582201:G:GAacceptor_gain1.0000
19:52582201:GA:Gacceptor_gain1.0000
19:52582201:GAT:Gacceptor_gain1.0000
19:52582201:GATA:Gacceptor_gain1.0000
19:52582201:GATAC:Gacceptor_gain1.0000
19:52570326:CGGCG:Cdonor_gain0.9900
19:52570327:GGCGG:Gdonor_gain0.9900
19:52570328:GCG:Gdonor_gain0.9900
19:52570329:CG:Cdonor_gain0.9900
19:52570330:GG:Gdonor_gain0.9900
19:52570332:T:Adonor_loss0.9900

AlphaMissense

3112 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:52583146:T:CF429L0.995
19:52583148:C:AF429L0.995
19:52583148:C:GF429L0.995
19:52583398:T:CF513L0.995
19:52583400:T:AF513L0.995
19:52583400:T:GF513L0.995
19:52583062:T:CF401L0.994
19:52583064:C:AF401L0.994
19:52583064:C:GF401L0.994
19:52582978:T:CF373L0.993
19:52582980:T:AF373L0.993
19:52582980:T:GF373L0.993
19:52583230:T:CF457L0.993
19:52583232:T:AF457L0.993
19:52583232:T:GF457L0.993
19:52583314:T:CF485L0.993
19:52583316:T:AF485L0.993
19:52583316:T:GF485L0.993
19:52582894:T:CF345L0.992
19:52582896:C:AF345L0.992
19:52582896:C:GF345L0.992
19:52583175:T:AH438Q0.987
19:52583175:T:GH438Q0.987
19:52583405:G:CR515P0.985
19:52575928:T:CF83L0.984
19:52575930:C:AF83L0.984
19:52575930:C:GF83L0.984
19:52583069:G:CR403P0.982
19:52583103:C:AH414Q0.982
19:52583103:C:GH414Q0.982

dbSNP variants (sampled 300 via entrez): RS1000079959 (19:52600642 A>C,G), RS1000152012 (19:52570141 G>A,C), RS1000176005 (19:52588461 T>A), RS1000278609 (19:52584333 G>A), RS1000331006 (19:52595390 C>G), RS1000424747 (19:52582040 C>G), RS1000447071 (19:52595640 G>T), RS1000473739 (19:52589059 T>C), RS1000538513 (19:52583487 C>G,T), RS1000609465 (19:52585165 G>A), RS1000623195 (19:52578147 G>A), RS1000766241 (19:52588785 C>T), RS1000821025 (19:52589572 C>A,T), RS1000823831 (19:52570845 A>G), RS1000868619 (19:52580692 C>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST003501_3Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)2.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:1001507asparaginase-induced acute pancreatitis

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases expression3
Benzo(a)pyreneincreases expression, increases methylation, decreases reaction2
Cadmium Chloridedecreases expression, increases abundance, increases expression2
GSK-J4decreases expression1
chlorophyllinincreases expression, decreases reaction1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
butyraldehydeincreases expression1
potassium chromate(VI)increases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
Temozolomideincreases expression1
Air Pollutantsaffects expression, increases abundance1
Cadmiumincreases abundance, increases expression1
Hydralazineaffects cotreatment, increases expression1
Ozoneaffects expression, increases abundance1
Tobacco Smoke Pollutionincreases expression1
Valproic Acidaffects cotreatment, increases expression1
Vanadatesdecreases expression1
Antirheumatic Agentsdecreases expression1
Copper Sulfateincreases expression1
Lactic Acidincreases expression1
Acrylamideincreases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_XW77HEK293 eGFP-ZNF701Transformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.